Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Use of antihistamine medications during early pregnancy and isolated major malformations.

Gilboa SM, Strickland MJ, Olshan AF, Werler MM, Correa A; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2009 Feb;85(2):137-50. doi: 10.1002/bdra.20513.

2.

Assessment of antihistamine use in early pregnancy and birth defects.

Li Q, Mitchell AA, Werler MM, Yau WP, Hernández-Díaz S.

J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):666-74.e1. doi: 10.1016/j.jaip.2013.07.008. Epub 2013 Sep 12.

3.

Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.

Reefhuis J, Devine O, Friedman JM, Louik C, Honein MA; National Birth Defects Prevention Study.

BMJ. 2015 Jul 8;351:h3190. doi: 10.1136/bmj.h3190. Review.

4.

Antihistamines and birth defects: a systematic review of the literature.

Gilboa SM, Ailes EC, Rai RP, Anderson JA, Honein MA.

Expert Opin Drug Saf. 2014 Dec;13(12):1667-98. doi: 10.1517/14740338.2014.970164. Epub 2014 Oct 11. Review.

5.

Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies.

Hansen C, Andrade SE, Freiman H, Dublin S, Haffenreffer K, Cooper WO, Cheetham TC, Toh S, Li DK, Raebel MA, Kuntz JL, Perrin N, Rosales AG, Carter S, Pawloski PA, Maloney EM, Graham DJ, Sahin L, Scott PE, Yap J, Davis R.

Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):170-8. doi: 10.1002/pds.3919. Epub 2015 Nov 24.

6.

Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.

Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K, Kosuga Y, Suzuki M, Matsumoto M, Kunii Y, Watanabe N, Mukasa K, Ito K, Ito K.

J Clin Endocrinol Metab. 2012 Jul;97(7):2396-403. doi: 10.1210/jc.2011-2860. Epub 2012 Apr 30.

PMID:
22547422
7.

Valproic acid monotherapy in pregnancy and major congenital malformations.

Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT; EUROCAT Antiepileptic Study Working Group.

N Engl J Med. 2010 Jun 10;362(23):2185-93. doi: 10.1056/NEJMoa0907328. Review.

8.

Lamotrigine and the risk of malformations in pregnancy.

Cunnington M, Tennis P; International Lamotrigine Pregnancy Registry Scientific Advisory Committee.

Neurology. 2005 Mar 22;64(6):955-60.

PMID:
15781807
9.

Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.

Anderka M, Mitchell AA, Louik C, Werler MM, Hernández-Diaz S, Rasmussen SA; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2012 Jan;94(1):22-30. doi: 10.1002/bdra.22865. Epub 2011 Nov 19.

10.

First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.

Cassina M, Donà M, Di Gianantonio E, Litta P, Clementi M.

Hum Reprod Update. 2014 Sep-Oct;20(5):656-69. doi: 10.1093/humupd/dmu022. Epub 2014 May 25. Review.

PMID:
24861556
11.

First-trimester exposure to bupropion and risk of cardiac malformations.

Louik C, Kerr S, Mitchell AA.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1066-75. doi: 10.1002/pds.3661. Epub 2014 Jun 12.

PMID:
24920293
12.

Safety of antihistamines during pregnancy and lactation.

So M, Bozzo P, Inoue M, Einarson A.

Can Fam Physician. 2010 May;56(5):427-9.

13.

Maternal asthma medication use and the risk of selected birth defects.

Lin S, Munsie JP, Herdt-Losavio ML, Druschel CM, Campbell K, Browne ML, Romitti PA, Olney RS, Bell EM; National Birth Defects Prevention Study.

Pediatrics. 2012 Feb;129(2):e317-24. doi: 10.1542/peds.2010-2660. Epub 2012 Jan 16.

PMID:
22250027
14.

Maternal asthma, asthma medication use, and the risk of congenital heart defects.

Lin S, Herdt-Losavio M, Gensburg L, Marshall E, Druschel C.

Birth Defects Res A Clin Mol Teratol. 2009 Feb;85(2):161-8. doi: 10.1002/bdra.20523.

PMID:
19067406
15.

Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study.

Nezvalová-Henriksen K, Spigset O, Nordeng H.

Headache. 2010 Apr;50(4):563-75. doi: 10.1111/j.1526-4610.2010.01619.x. Epub 2010 Jan 28. Erratum in: Headache. 2012 Sep;52(8):1319-20.

PMID:
20132339
16.

Allergy Medications During Pregnancy.

Gonzalez-Estrada A, Geraci SA.

Am J Med Sci. 2016 Sep;352(3):326-31. doi: 10.1016/j.amjms.2016.05.030. Epub 2016 Jun 3. Review.

PMID:
27650241
17.

Early pregnancy exposure to antihistamines and risk of congenital heart defects: results of two case-control studies.

Smedts HP, de Jonge L, Bandola SJ, Baardman ME, Bakker MK, Stricker BH, Steegers-Theunissen RP.

Eur J Epidemiol. 2014 Sep;29(9):653-61. doi: 10.1007/s10654-014-9925-0. Epub 2014 Jun 20.

PMID:
24947638
18.

Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.

Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S.

Arch Neurol. 2011 Oct;68(10):1275-81. doi: 10.1001/archneurol.2011.133. Epub 2011 Jun 13.

PMID:
21670385
19.

Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations.

Brender JD, Werler MM, Shinde MU, Vuong AM, Kelley KE, Huber JC Jr, Sharkey JR, Griesenbeck JS, Romitti PA, Malik S, Suarez L, Langlois PH, Canfield MA; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2012 Sep;94(9):701-13. doi: 10.1002/bdra.23060. Epub 2012 Aug 18.

20.

First-trimester antihistamine exposure and risk of spontaneous abortion or preterm birth.

Aldridge TD, Hartmann KE, Michels KA, Velez Edwards DR.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1043-50. doi: 10.1002/pds.3637. Epub 2014 May 1.

Supplemental Content

Support Center